Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ira Kurtz is a Nephrologist in Los Angeles, California. Kurtz has been practicing medicine for over 46 years and is rated as an Elite expert by MediFind in the treatment of Primary Tubular Proximal Acidosis. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Renal Tubular Acidosis, Proximal Renal Tubular Acidosis, Primary Tubular Proximal Acidosis, and Autosomal Dominant Distal Renal Tubular Acidosis. He is licensed to treat patients in California. Kurtz is currently accepting new patients.
Emmanuelle Cordat practices in Edmonton, Canada. Cordat is rated as an Elite expert by MediFind in the treatment of Primary Tubular Proximal Acidosis. She is also highly rated in 10 other conditions, according to our data. Her top areas of expertise are Renal Tubular Acidosis, Primary Tubular Proximal Acidosis, Proximal Renal Tubular Acidosis, and Low Potassium Level.
Detlef Bockenhauer practices in London, United Kingdom. Bockenhauer is rated as an Elite expert by MediFind in the treatment of Primary Tubular Proximal Acidosis. They are also highly rated in 52 other conditions, according to our data. Their top areas of expertise are Proximal Renal Tubular Acidosis, Primary Tubular Proximal Acidosis, Fanconi Syndrome, Fanconi Bickel Syndrome, and Kidney Transplant.
Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer. These cancer-...
Summary: Head and neck squamous cell carcinoma (HNSCC) encompasses a variety of tumors originating in the lip, oral cavity, hypopharynx, oropharynx, nasopharynx and larynx. It is the sixth most common malignancy worldwide accounting for approximately 6% of all cancer cases (Rettig and D'Souza., 2015). HNSCC represents the third most common cause of cancer death worldwide. Platinum based regimens represent ...